APO Research
Talk to an analyst

APO RESEARCH · REPORT

CRO in Clinical Trials

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global CRO in Clinical Trials Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchCRO in Clinical Trials Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal CRO in Clinical Trials Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal CRO in Clinical Trials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CRO in Clinical Trials Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal CRO in Clinical Trials Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global CRO in Clinical Trials market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for CRO in Clinical Trials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the CRO in Clinical Trials market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the CRO in Clinical Trials market include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, MedPace and Wuxi AppTec, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global CRO in Clinical Trials market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of CRO in Clinical Trials and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents CRO in Clinical Trials revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global CRO in Clinical Trials market.

CRO in Clinical Trials Segment by Company

Labcorp

IQVIA

Parexel

Syneos Health

PRA Health Sciences

PPD

ICON

MedPace

Wuxi AppTec

CRO in Clinical Trials Segment by Type

Phase I Trial

Phase II Trial

Phase III Trial

Phase IV Trial

CRO in Clinical Trials Segment by End User

Pharmaceutical

Bio-pharm

Others

CRO in Clinical Trials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global CRO in Clinical Trials status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the CRO in Clinical Trials key companies, revenue, market share, and recent developments.

3. To split the CRO in Clinical Trials breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions CRO in Clinical Trials market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify CRO in Clinical Trials significant trends, drivers, influence factors in global and regions.

6. To analyze CRO in Clinical Trials competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRO in Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CRO in Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRO in Clinical Trials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CRO in Clinical Trials industry.

Chapter 3: Detailed analysis of CRO in Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of CRO in Clinical Trials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of CRO in Clinical Trials in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. CRO in Clinical Trials Industry Trends Table 2. CRO in Clinical Trials Industry Drivers Table 3. CRO in Clinical Trials Industry Opportunities and Challenges Table 4. CRO in Clinical Trials Industry Restraints Table 5. Global CRO in Clinical Trials Revenue by Company (US$ Million) & (2021-2026) Table 6. Global CRO in Clinical Trials Revenue Share by Company (2021-2026) Table 7. Global CRO in Clinical Trials Company Ranking, (2024-2026) & (US$ Million) Table 8. Global CRO in Clinical Trials Key Company Manufacturing Base & Headquarters Table 9. Global CRO in Clinical Trials Company, Product Type & Application Table 10. Global CRO in Clinical Trials Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global CRO in Clinical Trials by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Phase I Trial Table 15. Significant Companies of Phase II Trial Table 16. Significant Companies of Phase III Trial Table 17. Significant Companies of Phase IV Trial Table 18. Global CRO in Clinical Trials Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global CRO in Clinical Trials Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global CRO in Clinical Trials Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global CRO in Clinical Trials Sales Value Share by Type (2021-2026) Table 22. Global CRO in Clinical Trials Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Table 24. Significant Companies of Bio-pharm Table 25. Significant Companies of Others Table 26. Global CRO in Clinical Trials Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global CRO in Clinical Trials Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global CRO in Clinical Trials Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global CRO in Clinical Trials Sales Value Share by Application (2021-2026) Table 30. Global CRO in Clinical Trials Sales Value Share by Application (2027-2032) Table 31. Global CRO in Clinical Trials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global CRO in Clinical Trials Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global CRO in Clinical Trials Sales Value Share by Region (2021-2026) Table 34. Global CRO in Clinical Trials Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global CRO in Clinical Trials Sales Value Share by Region (2027-2032) Table 36. Global CRO in Clinical Trials Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global CRO in Clinical Trials Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global CRO in Clinical Trials Sales Value Market Share by Country (2021-2026) Table 39. Global CRO in Clinical Trials Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global CRO in Clinical Trials Sales Value Market Share by Country (2027-2032) Table 41. Labcorp Company Information Table 42. Labcorp Business Overview Table 43. Labcorp CRO in Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Labcorp CRO in Clinical Trials Product Portfolio Table 45. Labcorp Recent Development Table 46. IQVIA Company Information Table 47. IQVIA Business Overview Table 48. IQVIA CRO in Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. IQVIA CRO in Clinical Trials Product Portfolio Table 50. IQVIA Recent Development Table 51. Parexel Company Information Table 52. Parexel Business Overview Table 53. Parexel CRO in Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Parexel CRO in Clinical Trials Product Portfolio Table 55. Parexel Recent Development Table 56. Syneos Health Company Information Table 57. Syneos Health Business Overview Table 58. Syneos Health CRO in Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Syneos Health CRO in Clinical Trials Product Portfolio Table 60. Syneos Health Recent Development Table 61. PRA Health Sciences Company Information Table 62. PRA Health Sciences Business Overview Table 63. PRA Health Sciences CRO in Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. PRA Health Sciences CRO in Clinical Trials Product Portfolio Table 65. PRA Health Sciences Recent Development Table 66. PPD Company Information Table 67. PPD Business Overview Table 68. PPD CRO in Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. PPD CRO in Clinical Trials Product Portfolio Table 70. PPD Recent Development Table 71. ICON Company Information Table 72. ICON Business Overview Table 73. ICON CRO in Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. ICON CRO in Clinical Trials Product Portfolio Table 75. ICON Recent Development Table 76. MedPace Company Information Table 77. MedPace Business Overview Table 78. MedPace CRO in Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. MedPace CRO in Clinical Trials Product Portfolio Table 80. MedPace Recent Development Table 81. Wuxi AppTec Company Information Table 82. Wuxi AppTec Business Overview Table 83. Wuxi AppTec CRO in Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Wuxi AppTec CRO in Clinical Trials Product Portfolio Table 85. Wuxi AppTec Recent Development Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. CRO in Clinical Trials Product Image Figure 2. Global CRO in Clinical Trials Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CRO in Clinical Trials Market Size (2021-2032) & (US$ Million) Figure 4. Global CRO in Clinical Trials Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Phase I Trial Image Figure 8. Phase II Trial Image Figure 9. Phase III Trial Image Figure 10. Phase IV Trial Image Figure 11. Global CRO in Clinical Trials Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global CRO in Clinical Trials Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global CRO in Clinical Trials Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Image Figure 15. Bio-pharm Image Figure 16. Others Image Figure 17. Global CRO in Clinical Trials Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global CRO in Clinical Trials Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global CRO in Clinical Trials Sales Value Share by Application (2021-2032) Figure 20. Global CRO in Clinical Trials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global CRO in Clinical Trials Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America CRO in Clinical Trials Sales Value (2021-2032) & (US$ Million) Figure 23. North America CRO in Clinical Trials Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe CRO in Clinical Trials Sales Value (2021-2032) & (US$ Million) Figure 25. Europe CRO in Clinical Trials Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific CRO in Clinical Trials Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific CRO in Clinical Trials Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America CRO in Clinical Trials Sales Value (2021-2032) & (US$ Million) Figure 29. South America CRO in Clinical Trials Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa CRO in Clinical Trials Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa CRO in Clinical Trials Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt CRO in Clinical Trials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Phase I Trial
  • Phase II Trial
  • Phase III Trial
  • Phase IV Trial
Applications
  • Pharmaceutical
  • Bio-pharm
  • Others
Companies covered
  • Labcorp
  • IQVIA
  • Parexel
  • Syneos Health
  • PRA Health Sciences
  • PPD
  • ICON
  • MedPace
  • Wuxi AppTec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global CRO in Clinical Trials Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global CRO in Clinical Trials Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 CRO in Clinical Trials Market Dynamics
  1. 2.1 CRO in Clinical Trials Industry Trends
  2. 2.2 CRO in Clinical Trials Industry Drivers
  3. 2.3 CRO in Clinical Trials Industry Opportunities and Challenges
  4. 2.4 CRO in Clinical Trials Industry Restraints
3 CRO in Clinical Trials Market by Company
  1. 3.1 Global CRO in Clinical Trials Company Revenue Ranking in 2025
  2. 3.2 Global CRO in Clinical Trials Revenue by Company (2021-2026)
  3. 3.3 Global CRO in Clinical Trials Company Ranking (2024-2026)
  4. 3.4 Global CRO in Clinical Trials Company Manufacturing Base and Headquarters
  5. 3.5 Global CRO in Clinical Trials Company Product Type and Application
  6. 3.6 Global CRO in Clinical Trials Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global CRO in Clinical Trials Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 CRO in Clinical Trials Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 CRO in Clinical Trials Market by Type
  1. 4.1 CRO in Clinical Trials Type Introduction
  2. 4.1.1 Phase I Trial
  3. 4.1.2 Phase II Trial
  4. 4.1.3 Phase III Trial
  5. 4.1.4 Phase IV Trial
  6. 4.2 Global CRO in Clinical Trials Sales Value by Type
  7. 4.2.1 Global CRO in Clinical Trials Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global CRO in Clinical Trials Sales Value by Type (2021-2032)
  9. 4.2.3 Global CRO in Clinical Trials Sales Value Share by Type (2021-2032)
5 CRO in Clinical Trials Market by Application
  1. 5.1 CRO in Clinical Trials Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Bio-pharm
  4. 5.1.3 Others
  5. 5.2 Global CRO in Clinical Trials Sales Value by Application
  6. 5.2.1 Global CRO in Clinical Trials Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global CRO in Clinical Trials Sales Value by Application (2021-2032)
  8. 5.2.3 Global CRO in Clinical Trials Sales Value Share by Application (2021-2032)
6 CRO in Clinical Trials Regional Value Analysis
  1. 6.1 Global CRO in Clinical Trials Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global CRO in Clinical Trials Sales Value by Region (2021-2032)
  3. 6.2.1 Global CRO in Clinical Trials Sales Value by Region: 2021-2026
  4. 6.2.2 Global CRO in Clinical Trials Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America CRO in Clinical Trials Sales Value (2021-2032)
  7. 6.3.2 North America CRO in Clinical Trials Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe CRO in Clinical Trials Sales Value (2021-2032)
  10. 6.4.2 Europe CRO in Clinical Trials Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific CRO in Clinical Trials Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific CRO in Clinical Trials Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America CRO in Clinical Trials Sales Value (2021-2032)
  16. 6.6.2 South America CRO in Clinical Trials Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa CRO in Clinical Trials Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa CRO in Clinical Trials Sales Value Share by Country, 2025 VS 2032
7 CRO in Clinical Trials Country-level Value Analysis
  1. 7.1 Global CRO in Clinical Trials Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global CRO in Clinical Trials Sales Value by Country (2021-2032)
  3. 7.2.1 Global CRO in Clinical Trials Sales Value by Country (2021-2026)
  4. 7.2.2 Global CRO in Clinical Trials Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt CRO in Clinical Trials Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt CRO in Clinical Trials Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt CRO in Clinical Trials Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Labcorp
  2. 8.1.1 Labcorp Company Information
  3. 8.1.2 Labcorp Business Overview
  4. 8.1.3 Labcorp CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Labcorp CRO in Clinical Trials Product Portfolio
  6. 8.1.5 Labcorp Recent Developments
  7. 8.2 IQVIA
  8. 8.2.1 IQVIA Company Information
  9. 8.2.2 IQVIA Business Overview
  10. 8.2.3 IQVIA CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  11. 8.2.4 IQVIA CRO in Clinical Trials Product Portfolio
  12. 8.2.5 IQVIA Recent Developments
  13. 8.3 Parexel
  14. 8.3.1 Parexel Company Information
  15. 8.3.2 Parexel Business Overview
  16. 8.3.3 Parexel CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Parexel CRO in Clinical Trials Product Portfolio
  18. 8.3.5 Parexel Recent Developments
  19. 8.4 Syneos Health
  20. 8.4.1 Syneos Health Company Information
  21. 8.4.2 Syneos Health Business Overview
  22. 8.4.3 Syneos Health CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Syneos Health CRO in Clinical Trials Product Portfolio
  24. 8.4.5 Syneos Health Recent Developments
  25. 8.5 PRA Health Sciences
  26. 8.5.1 PRA Health Sciences Company Information
  27. 8.5.2 PRA Health Sciences Business Overview
  28. 8.5.3 PRA Health Sciences CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PRA Health Sciences CRO in Clinical Trials Product Portfolio
  30. 8.5.5 PRA Health Sciences Recent Developments
  31. 8.6 PPD
  32. 8.6.1 PPD Company Information
  33. 8.6.2 PPD Business Overview
  34. 8.6.3 PPD CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PPD CRO in Clinical Trials Product Portfolio
  36. 8.6.5 PPD Recent Developments
  37. 8.7 ICON
  38. 8.7.1 ICON Company Information
  39. 8.7.2 ICON Business Overview
  40. 8.7.3 ICON CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ICON CRO in Clinical Trials Product Portfolio
  42. 8.7.5 ICON Recent Developments
  43. 8.8 MedPace
  44. 8.8.1 MedPace Company Information
  45. 8.8.2 MedPace Business Overview
  46. 8.8.3 MedPace CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MedPace CRO in Clinical Trials Product Portfolio
  48. 8.8.5 MedPace Recent Developments
  49. 8.9 Wuxi AppTec
  50. 8.9.1 Wuxi AppTec Company Information
  51. 8.9.2 Wuxi AppTec Business Overview
  52. 8.9.3 Wuxi AppTec CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wuxi AppTec CRO in Clinical Trials Product Portfolio
  54. 8.9.5 Wuxi AppTec Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst